Clinical Trial Update: Growth Hormone Deficiency in Adults (GHDA) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating growth hormone therapy for adults with growth hormone deficiency has completed; the update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 3 | Status: COMPLETED